US Stock MarketDetailed Quotes

Evofem Biosciences (EVFM)

Watchlist
  • 0.0089
  • 0.00000.00%
15min DelayClose Apr 16 15:50 ET
1.18MMarket Cap-0.18P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Evofem Biosciences (EVFM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
4.23%20.18M
34.59%9.56M
10.14%4.95M
15.99%4.83M
-76.55%845K
6.28%19.36M
46.81%7.1M
-12.05%4.5M
69.24%4.16M
-37.98%3.6M
Operating revenue
4.23%20.18M
34.59%9.56M
10.14%4.95M
15.99%4.83M
-76.55%845K
6.28%19.36M
46.81%7.1M
-12.05%4.5M
69.24%4.16M
-37.98%3.6M
Cost of revenue
20.42%4.62M
71.43%2.59M
4.14%905K
-1.82%755K
-46.64%365K
-41.12%3.83M
58.49%1.51M
-54.00%869K
-66.46%769K
-50.29%684K
Gross profit
0.24%15.57M
24.62%6.97M
11.58%4.05M
20.02%4.07M
-83.56%480K
32.66%15.53M
43.94%5.59M
12.53%3.63M
1,955.15%3.39M
-34.15%2.92M
Operating expense
-39.12%14.13M
-45.05%3.62M
-17.11%5.03M
11.32%5.32M
-97.35%153K
-21.48%23.21M
-9.22%6.6M
-10.45%6.07M
-36.28%4.78M
-28.07%5.76M
Selling and administrative expenses
-17.68%17.08M
-43.80%3.16M
-17.57%4.48M
-0.93%4.47M
-3.95%4.97M
-22.07%20.74M
-4.32%5.63M
-11.80%5.43M
-36.47%4.51M
-30.82%5.17M
-Selling and marketing expense
5.51%9.68M
-6.35%2.07M
0.38%2.39M
17.03%2.63M
10.87%2.6M
-21.33%9.18M
-16.06%2.21M
-20.20%2.38M
2.09%2.24M
-39.15%2.35M
-General and administrative expense
-36.07%7.39M
-67.94%1.1M
-31.59%2.09M
-18.70%1.84M
-16.25%2.37M
-22.64%11.57M
5.16%3.42M
-3.90%3.05M
-53.75%2.27M
-21.95%2.82M
Research and development costs
-286.83%-3.45M
-42.68%372K
41.57%470K
176.30%746K
----
-37.22%1.85M
-53.07%649K
-45.93%332K
-32.84%270K
10.00%594K
Depreciation amortization depletion
-19.39%499K
-72.01%89K
-73.42%80K
--107K
--223K
--619K
--318K
--301K
--0
--0
-Depreciation and amortization
-19.39%499K
-72.01%89K
-73.42%80K
--107K
--223K
--619K
--318K
--301K
--0
--0
Other operating expenses
----
----
----
----
---5.04M
----
----
----
----
----
Operating profit
118.75%1.44M
433.50%3.35M
59.75%-982K
9.94%-1.25M
111.50%327K
56.99%-7.68M
70.33%-1M
31.31%-2.44M
81.07%-1.39M
20.54%-2.84M
Net non-operating interest income expense
-6.25%15K
-33.33%2K
0.00%3K
-66.67%2K
100.00%8K
-48.39%16K
0.00%3K
50.00%3K
-25.00%6K
-77.78%4K
Non-operating interest income
-6.25%15K
-33.33%2K
0.00%3K
-66.67%2K
100.00%8K
-48.39%16K
0.00%3K
50.00%3K
-25.00%6K
-77.78%4K
Other net income (expense)
11.58%-1.06M
72.51%-560K
-1,028.13%-594K
-119.26%-528K
131.54%621K
-101.69%-1.2M
-261.28%-2.04M
-99.91%64K
323.47%2.74M
-262.73%-1.97M
Gain on sale of security
-190.20%-359K
110.93%131K
-339.92%-1.85M
-95.94%134K
52.24%1.22M
120.98%398K
-164.76%-1.2M
114.86%769K
3,400.00%3.3M
-50.25%802K
Special income (charges)
97.85%1.93M
--0
1,451.75%1.93M
--0
--0
-98.70%977K
--0
-100.19%-143K
--0
--1.12M
-Less：Restructuring and merger&acquisition
---1.93M
--0
---1.93M
----
----
--0
--0
--0
----
----
-Less:Other special charges
----
----
----
----
----
98.70%-977K
--0
100.19%143K
----
---1.12M
Other non- operating income (expenses)
-2.33%-2.64M
17.64%-691K
-21.35%-682K
-18.64%-662K
84.58%-600K
2.02%-2.58M
-42.93%-839K
5.70%-562K
50.49%-558K
-867.91%-3.89M
Income before tax
104.44%393K
191.77%2.79M
33.71%-1.57M
-230.76%-1.78M
119.88%956K
-116.72%-8.86M
-43.66%-3.04M
-103.59%-2.37M
115.89%1.36M
-104.55%-4.81M
Income tax
2K
-1K
50.00%-4K
-12.50%7K
0
0
0
-172.73%-8K
166.67%8K
0
Net income
104.41%391K
191.80%2.79M
33.66%-1.57M
-232.05%-1.78M
119.88%956K
-116.72%-8.86M
-43.66%-3.04M
-103.58%-2.37M
115.79%1.35M
-104.29%-4.81M
Net income continuous Operations
104.41%391K
191.80%2.79M
33.66%-1.57M
-232.05%-1.78M
119.88%956K
-116.72%-8.86M
-43.66%-3.04M
-103.58%-2.37M
115.79%1.35M
-104.29%-4.81M
Minority interest income
Net income attributable to the parent company
104.41%391K
191.80%2.79M
33.66%-1.57M
-232.05%-1.78M
119.88%956K
-116.72%-8.86M
-43.66%-3.04M
-103.58%-2.37M
115.79%1.35M
-104.29%-4.81M
Preferred stock dividends
11.43%117K
-66.67%2K
2,120.00%111K
-97.87%1K
-93.62%3K
-96.48%105K
6K
5K
47K
47K
Other preferred stock dividends
Net income attributable to common stockholders
103.06%274K
191.55%2.79M
29.11%-1.68M
-236.89%-1.79M
119.63%953K
-117.93%-8.97M
40.31%-3.04M
-103.59%-2.37M
115.24%1.3M
-106.29%-4.86M
Basic earnings per share
0
166.67%0.02
50.00%-0.01
-200.00%-0.02
106.25%0.01
-101.06%-0.11
88.23%-0.03
-100.13%-0.02
100.37%0.02
91.35%-0.16
Diluted earnings per share
0
166.67%0.02
50.00%-0.01
-0.02
0
-320.00%-0.11
94.63%-0.03
-120.00%-0.02
0
91.35%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 4.23%20.18M34.59%9.56M10.14%4.95M15.99%4.83M-76.55%845K6.28%19.36M46.81%7.1M-12.05%4.5M69.24%4.16M-37.98%3.6M
Operating revenue 4.23%20.18M34.59%9.56M10.14%4.95M15.99%4.83M-76.55%845K6.28%19.36M46.81%7.1M-12.05%4.5M69.24%4.16M-37.98%3.6M
Cost of revenue 20.42%4.62M71.43%2.59M4.14%905K-1.82%755K-46.64%365K-41.12%3.83M58.49%1.51M-54.00%869K-66.46%769K-50.29%684K
Gross profit 0.24%15.57M24.62%6.97M11.58%4.05M20.02%4.07M-83.56%480K32.66%15.53M43.94%5.59M12.53%3.63M1,955.15%3.39M-34.15%2.92M
Operating expense -39.12%14.13M-45.05%3.62M-17.11%5.03M11.32%5.32M-97.35%153K-21.48%23.21M-9.22%6.6M-10.45%6.07M-36.28%4.78M-28.07%5.76M
Selling and administrative expenses -17.68%17.08M-43.80%3.16M-17.57%4.48M-0.93%4.47M-3.95%4.97M-22.07%20.74M-4.32%5.63M-11.80%5.43M-36.47%4.51M-30.82%5.17M
-Selling and marketing expense 5.51%9.68M-6.35%2.07M0.38%2.39M17.03%2.63M10.87%2.6M-21.33%9.18M-16.06%2.21M-20.20%2.38M2.09%2.24M-39.15%2.35M
-General and administrative expense -36.07%7.39M-67.94%1.1M-31.59%2.09M-18.70%1.84M-16.25%2.37M-22.64%11.57M5.16%3.42M-3.90%3.05M-53.75%2.27M-21.95%2.82M
Research and development costs -286.83%-3.45M-42.68%372K41.57%470K176.30%746K-----37.22%1.85M-53.07%649K-45.93%332K-32.84%270K10.00%594K
Depreciation amortization depletion -19.39%499K-72.01%89K-73.42%80K--107K--223K--619K--318K--301K--0--0
-Depreciation and amortization -19.39%499K-72.01%89K-73.42%80K--107K--223K--619K--318K--301K--0--0
Other operating expenses -------------------5.04M--------------------
Operating profit 118.75%1.44M433.50%3.35M59.75%-982K9.94%-1.25M111.50%327K56.99%-7.68M70.33%-1M31.31%-2.44M81.07%-1.39M20.54%-2.84M
Net non-operating interest income expense -6.25%15K-33.33%2K0.00%3K-66.67%2K100.00%8K-48.39%16K0.00%3K50.00%3K-25.00%6K-77.78%4K
Non-operating interest income -6.25%15K-33.33%2K0.00%3K-66.67%2K100.00%8K-48.39%16K0.00%3K50.00%3K-25.00%6K-77.78%4K
Other net income (expense) 11.58%-1.06M72.51%-560K-1,028.13%-594K-119.26%-528K131.54%621K-101.69%-1.2M-261.28%-2.04M-99.91%64K323.47%2.74M-262.73%-1.97M
Gain on sale of security -190.20%-359K110.93%131K-339.92%-1.85M-95.94%134K52.24%1.22M120.98%398K-164.76%-1.2M114.86%769K3,400.00%3.3M-50.25%802K
Special income (charges) 97.85%1.93M--01,451.75%1.93M--0--0-98.70%977K--0-100.19%-143K--0--1.12M
-Less：Restructuring and merger&acquisition ---1.93M--0---1.93M----------0--0--0--------
-Less:Other special charges --------------------98.70%-977K--0100.19%143K-------1.12M
Other non- operating income (expenses) -2.33%-2.64M17.64%-691K-21.35%-682K-18.64%-662K84.58%-600K2.02%-2.58M-42.93%-839K5.70%-562K50.49%-558K-867.91%-3.89M
Income before tax 104.44%393K191.77%2.79M33.71%-1.57M-230.76%-1.78M119.88%956K-116.72%-8.86M-43.66%-3.04M-103.59%-2.37M115.89%1.36M-104.55%-4.81M
Income tax 2K-1K50.00%-4K-12.50%7K000-172.73%-8K166.67%8K0
Net income 104.41%391K191.80%2.79M33.66%-1.57M-232.05%-1.78M119.88%956K-116.72%-8.86M-43.66%-3.04M-103.58%-2.37M115.79%1.35M-104.29%-4.81M
Net income continuous Operations 104.41%391K191.80%2.79M33.66%-1.57M-232.05%-1.78M119.88%956K-116.72%-8.86M-43.66%-3.04M-103.58%-2.37M115.79%1.35M-104.29%-4.81M
Minority interest income
Net income attributable to the parent company 104.41%391K191.80%2.79M33.66%-1.57M-232.05%-1.78M119.88%956K-116.72%-8.86M-43.66%-3.04M-103.58%-2.37M115.79%1.35M-104.29%-4.81M
Preferred stock dividends 11.43%117K-66.67%2K2,120.00%111K-97.87%1K-93.62%3K-96.48%105K6K5K47K47K
Other preferred stock dividends
Net income attributable to common stockholders 103.06%274K191.55%2.79M29.11%-1.68M-236.89%-1.79M119.63%953K-117.93%-8.97M40.31%-3.04M-103.59%-2.37M115.24%1.3M-106.29%-4.86M
Basic earnings per share 0166.67%0.0250.00%-0.01-200.00%-0.02106.25%0.01-101.06%-0.1188.23%-0.03-100.13%-0.02100.37%0.0291.35%-0.16
Diluted earnings per share 0166.67%0.0250.00%-0.01-0.020-320.00%-0.1194.63%-0.03-120.00%-0.02091.35%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -